VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | The prognostic impact of TP53 mutation in MPNs

Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, briefly discusses the prognostic impact of TP53 mutation in myeloproliferative neoplasms (MPNs). This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter